Stig Egil Bojesen

Stig Egil Bojesen

Clinical Professor


  1. 2020
  2. Published

    Tocilizumab and soluble interleukin-6 receptor in JAK2V617F somatic mutation and myeloproliferative neoplasm

    Pedersen, K. M., Çolak, Y., Hasselbalch, Hans Carl, Bojesen, Stig Egil & Nordestgaard, Børge, 2020, In : EClinicalMedicine. 22, 100337.

    Research output: Contribution to journalComment/debateResearchpeer-review

  3. Published

    Transcriptome-wide association study of breast cancer risk by estrogen-receptor status

    Feng, H., Gusev, A., Pasaniuc, B., Wu, L., Long, J., Abu-full, Z., Aittomäki, K., Andrulis, I. L., Anton-Culver, H., Antoniou, A. C., Arason, A., Arndt, V., Aronson, K. J., Arun, B. K., Asseryanis, E., Auer, P. L., Azzollini, J., Balmaña, J., Barkardottir, R. B., Barnes, D. R., Barrowdale, D., Beckmann, M. W., Behrens, S., Benitez, J., Bermisheva, M., Białkowska, K., Blanco, A., Blomqvist, C., Boeckx, B., Bogdanova, N. V., Bojesen, Stig Egil, Bolla, M. K., Bonanni, B., Borg, A., Brauch, H., Brenner, H., Briceno, I., Broeks, A., Brüning, T., Burwinkel, B., Cai, Q., Caldés, T., Caligo, M. A., Campbell, I., Canisius, S., Christiansen, H., Ejlertsen, Bent Laursen, Flyger, H., Nielsen, Finn Cilius, Wang, Q., ABCTB Investigators, A. I., HEBON Investigators, H. I., BCFR Investigators, B. I., OCGN Investigators, O. I., GEMO Study Collaborators, G. S. C., EMBRACE Collaborators, E. C. & GC-HBOC Study Collaborators, G. S. C., 2020, In : Genetic Epidemiology. 44, 5, p. 442-468

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Published

    Two-fold risk of pneumonia and respiratory mortality in individuals with myeloproliferative neoplasm: A population-based cohort study

    Pedersen, K. M., Çolak, Y., Hasselbalch, Hans Carl, Ellervik, Christina, Nordestgaard, Børge & Bojesen, Stig Egil, 2020, In : EClinicalMedicine. 21, 100295.

    Research output: Contribution to journalJournal articleResearchpeer-review

Previous 1 2 3 Next

ID: 919364